NCT02061293 - A Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol Dependence | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

July 30, 2021

Study Completion Date

July 30, 2021

Conditions

Alcohol Dependence

Interventions

DRUG

Psilocybin

DRUG

Diphenhydramine

BEHAVIORAL

Motivational Enhancement and Taking Action (META)

Manualized psychosocial intervention based on motivational enhancement therapy, functional analysis, and implementation of a change plan.

Trial Locations (2)

Clinical and Translational Science Institute, NYU Langone Medical Center, New York

University of New Mexico Health Sciences Center, Albuquerque